메뉴 건너뛰기




Volumn 17, Issue 1, 2010, Pages 4-6

EGFR overexpression in squamous cell carcinoma of the penis

Author keywords

EGFR overexpression; Penile cancer

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

EID: 75849134466     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.v17i1.471     Document Type: Article
Times cited : (34)

References (16)
  • 2
    • 75849153398 scopus 로고    scopus 로고
    • Parkin DM, Whelan SL, Ferlay J, Storm H. Cancer Incidence in Five Continents [CD ROM]. Vols. I-VIII. International Agency for Research on Cancer (IARC) CancerBase series no. 7. Lyon, France: IARC Press; 2005.
    • Parkin DM, Whelan SL, Ferlay J, Storm H. Cancer Incidence in Five Continents [CD ROM]. Vols. I-VIII. International Agency for Research on Cancer (IARC) CancerBase series no. 7. Lyon, France: IARC Press; 2005.
  • 3
    • 0021165732 scopus 로고
    • Sequential trials of methotrexate, cisplatin and bleomycin for penile cancer
    • Ahmed T, Sklaroff R, Yagoda A. Sequential trials of methotrexate, cisplatin and bleomycin for penile cancer. J Urol 1984;132:465-8.
    • (1984) J Urol , vol.132 , pp. 465-468
    • Ahmed, T.1    Sklaroff, R.2    Yagoda, A.3
  • 4
    • 0024494281 scopus 로고
    • cis-Diamminedichloroplatinum in the treatment of advanced epidermoid carcinoma of the penis: A Southwest Oncology Group Study
    • Gagliano RG, Blumenstein BA, Crawford ED, Stephens RL, Coltman CA Jr, Costanzi JJ. cis-Diamminedichloroplatinum in the treatment of advanced epidermoid carcinoma of the penis: a Southwest Oncology Group Study. J Urol 1989;141:66-7.
    • (1989) J Urol , vol.141 , pp. 66-67
    • Gagliano, R.G.1    Blumenstein, B.A.2    Crawford, E.D.3    Stephens, R.L.4    Coltman Jr, C.A.5    Costanzi, J.J.6
  • 5
    • 0344378211 scopus 로고    scopus 로고
    • Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: A phase II study of methotrexate, cisplatin and bleomycin
    • Corral DA, Sella A, Pettaway CA, Amato RJ, Jones DM, Ellerhorst J. Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: a phase II study of methotrexate, cisplatin and bleomycin. J Urol 1998;160:1770-4.
    • (1998) J Urol , vol.160 , pp. 1770-1774
    • Corral, D.A.1    Sella, A.2    Pettaway, C.A.3    Amato, R.J.4    Jones, D.M.5    Ellerhorst, J.6
  • 6
    • 0032826430 scopus 로고    scopus 로고
    • Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: A Southwest Oncology Group study
    • Haas GP, Blumenstein BA, Gagliano RG, et al. Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study. J Urol 1999;161:1823-5.
    • (1999) J Urol , vol.161 , pp. 1823-1825
    • Haas, G.P.1    Blumenstein, B.A.2    Gagliano, R.G.3
  • 7
    • 0026554548 scopus 로고
    • Cisplatin and 5-fluorouracil in advanced cancer of the penis
    • Shammas FV, Ous S, Fossa SD. Cisplatin and 5-fluorouracil in advanced cancer of the penis. J Urol 1992;147:630-2.
    • (1992) J Urol , vol.147 , pp. 630-632
    • Shammas, F.V.1    Ous, S.2    Fossa, S.D.3
  • 8
    • 0032999409 scopus 로고    scopus 로고
    • Wells A. EGF receptor. Int J Biochem Cell Biol 1999;31: 637-43.
    • Wells A. EGF receptor. Int J Biochem Cell Biol 1999;31: 637-43.
  • 9
    • 0026316096 scopus 로고
    • Growth factors and cancer
    • Aaronson SA. Growth factors and cancer. Science 1991;254:1146-53.
    • (1991) Science , vol.254 , pp. 1146-1153
    • Aaronson, S.A.1
  • 10
    • 0028955388 scopus 로고
    • Epidermal growth factor-related peptides and their receptors in human malignancies
    • Salomon DS, Brandt R, Ciardiello F, Normanno N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Haematol 1995;19:183-232.
    • (1995) Crit Rev Oncol Haematol , vol.19 , pp. 183-232
    • Salomon, D.S.1    Brandt, R.2    Ciardiello, F.3    Normanno, N.4
  • 11
    • 0034722889 scopus 로고    scopus 로고
    • The EGF receptor family as targets for cancer therapy
    • Mendelsohn J, Baselga J. The EGF receptor family as targets for cancer therapy. Oncogene 2000;19:6550-65.
    • (2000) Oncogene , vol.19 , pp. 6550-6565
    • Mendelsohn, J.1    Baselga, J.2
  • 12
    • 22044445517 scopus 로고    scopus 로고
    • on behalf of the National Cancer Institute of Canada Clinical Trials Group. Erlotinib in previously treated non-small-cell lung cancer
    • Shepherd FA, Rodrigues Pereira J, Ciuleanu T, et al. on behalf of the National Cancer Institute of Canada Clinical Trials Group. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 2005;353:123-32.
    • (2005) N Engl J Med , vol.353 , pp. 123-132
    • Shepherd, F.A.1    Rodrigues Pereira, J.2    Ciuleanu, T.3
  • 13
    • 0037674062 scopus 로고    scopus 로고
    • Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck
    • Cohen EE, Rosen F, Stadler WM, et al. Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck. J Clin Oncol 2003;21:1980-7.
    • (2003) J Clin Oncol , vol.21 , pp. 1980-1987
    • Cohen, E.E.1    Rosen, F.2    Stadler, W.M.3
  • 14
    • 1842772526 scopus 로고    scopus 로고
    • Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck
    • Soulieres D, Senzer NN, Vokes EE, Hidalgo M, Agarwala SS, Siu LL. Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck. J Clin Oncol 2004;22:77-85.
    • (2004) J Clin Oncol , vol.22 , pp. 77-85
    • Soulieres, D.1    Senzer, N.N.2    Vokes, E.E.3    Hidalgo, M.4    Agarwala, S.S.5    Siu, L.L.6
  • 15
    • 34250180582 scopus 로고    scopus 로고
    • Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/ or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy
    • Vermorken JB, Trigo J, Hitt R, et al. Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/ or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy. J Clin Oncol 2007;25:2171-7.
    • (2007) J Clin Oncol , vol.25 , pp. 2171-2177
    • Vermorken, J.B.1    Trigo, J.2    Hitt, R.3
  • 16


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.